Omeprazole Magnesium | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Omeprazole Magnesium
US Exclusivities

TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Contact Supplier

Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

Contact Supplier

Omeprazole Magnesium

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Contact Supplier

pharmacompass-2-m-2025-11-03

Omeprazole Magnesium

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 16 USDMF, 10 CEP/COS, 7 EU WC, 8 NDC API, 14 Listed Suppliers, $ API Reference Price

29 API Suppliers
16 USDMF
10 CEP/COS
7 EU WC
8 NDC API
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

FINISHED DOSAGE FORMULATIONS

30 FDF Dossiers, 13 FDA Orange Book, 12 Canada, 5 Listed Dossiers

30 FDF Dossiers
13 FDA Orange Book
12 Canada
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 10MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 10MG BASE/PACKET
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET

RELATED EXCIPIENT COMPANIES

1 Minakem, 8 Evonik, 4 Rochem International Inc, 15 SPI Pharma, 16 DKSH, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 6 Kirsch Pharma, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 25 BASF, 4 CD Formulation, 14 Corel Pharma Chem, 3 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 3 Finar, 13 Gangwal Chemicals, 12 Ideal Cures, 1 Ingredion Pharma Solutions, 15 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 14 Roquette, 13 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

65 Coating Systems & Additives, 51 Fillers, Diluents & Binders, 40 Thickeners and Stabilizers, 37 Controlled & Modified Release, 33 Direct Compression, 30 Solubilizers, 26 Taste Masking, 22 Lubricants & Glidants, 22 Disintegrants & Superdisintegrants, 21 Granulation, 20 Topical, 18 Chewable & Orodispersible Aids, 18 Parenteral, 15 Film Formers & Plasticizers, 11 Rheology Modifiers, 10 Co-Processed Excipients, 10 Emulsifying Agents, 9 Empty Capsules, 6 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

65 Coating Systems & Additives
51 Fillers, Diluents & Binders
40 Thickeners and Stabilizers
37 Controlled & Modified Release
33 Direct Compression
30 Solubilizers
26 Taste Masking
22 Lubricants & Glidants
22 Disintegrants & Superdisintegrants
21 Granulation
20 Topical
18 Chewable & Orodispersible Aids
18 Parenteral
15 Film Formers & Plasticizers
11 Rheology Modifiers
10 Co-Processed Excipients
10 Emulsifying Agents
9 Empty Capsules
6 API Stability Enhancers
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

10 News #PharmaBuzz

10 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Regulatory FDF Prices

1 US Medicaid Prescriptions
1 Regulatory FDF Prices

MARKET PLACE

2 APIs, 1 FDF Dossiers

2 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 US Patents, 2 US Exclusivities, 18 Health Canada Patents

7 US Patents
2 US Exclusivities
18 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 1 Others

4 EDQM
1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 216 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

2 All

01 2TALICIA HOLDINGS

filter Product Reset all filters

2 All

01 2AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

filter Exclusivity Expiration Date Reset all filters

2 All

01 12022-11-01

02 12027-11-01

filter Exclusivity Code Reset all filters

2 All

01 1GAIN

02 1NP

Product Main Page

TALICIA HOLDINGS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

GAIN

Exclusivity Expiration Date

2027-11-01

Application Number

213004

Product Number

1

Exclusivity Details

01

TALICIA HOLDINGS

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

CTAD25

Not Confirmed

TALICIA HOLDINGS

Country

CTAD25

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Exclusivity Code : GAIN

Exclusivity Expiration Date : 2027-11-01

Application Number : 213004

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

TALICIA HOLDINGS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2022-11-01

Application Number

213004

Product Number

1

Exclusivity Details

02

TALICIA HOLDINGS

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

CTAD25

Not Confirmed

TALICIA HOLDINGS

Country

CTAD25

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Exclusivity Code : NP

Exclusivity Expiration Date : 2022-11-01

Application Number : 213004

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!